Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Schiff Insider Profile
4 Followers
Andrew Schiff, Director at Zeltiq Aesthetics, holds 438.96K shares in Aclaris Therapeutics (Ticker: ACRS), holds 2.10M shares in Zeltiq Aesthetics (Ticker: ZLTQ), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-10.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Schiff holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Schiff
Andrew Schiff's Trading History
Zeltiq Aesthetics
May 01, 2017
―
Uninformative Sell
―
$118.87M
Aclaris Therapeutics
Jun 05, 2023
Director
Uninformative Buy
―
$588.21K
Monte Rosa Therapeutics
―
Director
―
―
Agile Therapeutics
May 28, 2014
Director
Informative Buy
8.00M
$899.14K
List of latest transactions for each holding click on a transaction to see Andrew Schiff's performance on stock
You May Also Like
Andrew Schiff insider profile FAQ
What is the percentage of profitable transactions made by Andrew Schiff?
The percentage of profitable transactions made by Andrew Schiff is 25%.
What is the average return per transaction made by Andrew Schiff?
The average return per transaction made by Andrew Schiff is -10.90%.
What stocks does Andrew Schiff hold?
Andrew Schiff holds: ZLTQ, ACRS, GLUE, AGRX stocks.
What was Andrew Schiff’s latest transaction?
Andrew Schiff latest transaction was an Uninformative Buy of ―.
What was Andrew Schiff's most profitable transaction?
Andrew Schiff’s most profitable transaction was an Informative Buy of AGRX stock on May 28, 2014. The return on the trade was 67.40%.
What is Andrew Schiff's role in Zeltiq Aesthetics?
Andrew Schiff's role in Zeltiq Aesthetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.